1 not yet recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow 7MW3711: new trials by email Literature Review of 7MW3711 trials Research Report on 7MW3711
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy 7MW3711, Docetaxel - Lung Squamous Cell Carcinoma | Phase 3 | Not yet recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 600 | 2026-10-01 | 2026-09-21 |
| A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors 7MW3711, JS207, Cisplatin - Solid Tumor | Phase 1 / Phase 2 | Recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 280 | 2026-02-11 | 2026-03-12 |
Mabwell (Shanghai) Bioscience Co., Ltd. (2)
China (2)